Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Merck KGaA | 3.980% | 3.096% | 3.637% | -3.802% | 9.865% | 12.402% | 71.121% |
| Gerresheimer AG | 0.200% | -4.199% | 0.050% | -2.313% | 4.805% | 8.529% | 43.115% |
| Edwards Lifesciences Corp. | 0.440% | 0.100% | -5.889% | -2.751% | 15.196% | 8.412% | 347.091% |
| Insmed Inc. | -0.850% | -2.500% | -10.000% | 36.842% | -18.182% | 8.333% | -8.504% |
| Adocia | 1.840% | 8.983% | 4.299% | 167.634% | -21.599% | 7.836% | -46.270% |
| Johnson & Johnson | 0.390% | 1.215% | 0.865% | -5.601% | -1.201% | -0.200% | 14.578% |
| Takeda Pharmaceutical Co Ltd | -0.480% | 1.016% | -1.114% | -18.170% | -4.200% | -11.813% | -22.313% |
| AC Immune Ltd | -1.670% | 48.984% | 28.155% | 70.103% | -24.658% | -34.911% | - |
| Chromadex Corp | 0.630% | -9.714% | -17.277% | 135.821% | 135.821% | -44.561% | - |
| Align Technology | -0.080% | -3.602% | -13.268% | -5.080% | 2.760% | -45.154% | -10.253% |
| Cardiff Oncology Inc. | 3.660% | 4.362% | -38.593% | 106.786% | 145.441% | -53.857% | -7.714% |
| Ocular Therapeutix Inc. | 5.980% | 1.598% | -25.546% | -2.168% | 33.365% | -54.131% | 82.161% |
| Cytomx Therapeutics Inc | -0.500% | -53.020% | -11.260% | 9.352% | 28.152% | -73.398% | - |
| MacroGenics Inc. | -1.120% | -72.485% | -75.103% | -37.758% | -54.356% | -82.840% | - |
| Coherus Bioscien. | -1.300% | -8.142% | -8.710% | -57.519% | -36.908% | -83.322% | -87.672% |
| Novavax Inc. | -1.340% | 190.213% | 208.479% | 59.364% | 178.253% | -88.547% | 91.462% |
| Fibrogen Inc. | -3.990% | -13.672% | -10.717% | -93.196% | 27.384% | -93.837% | - |
| Fate Therapeutics Inc. | 5.480% | 6.663% | -29.219% | -16.205% | 8.043% | -93.911% | - |